Last reviewed: June 29, 2026
Last updated: June 29, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide is a GLP-1 receptor agonist that mimics a natural hormone controlling hunger and blood sugar, helping patients lose an average of 15% of body weight over 68 weeks in clinical trials. The medication requires a step-wise dosing approach—starting low and gradually increasing—to minimize side effects and allow your body to adapt. Understanding how semaglutide doses work empowers you to have informed conversations with your healthcare provider about your weight loss journey.
How Semaglutide Dosing Works for Weight Loss
Semaglutide dosing follows a titration schedule, meaning you begin with a small amount and increase it every week or two based on your tolerance and response. The standard starting dose is 0.25 mg injected subcutaneously once weekly. This low entry point allows your gastrointestinal system to adjust to the medication's appetite-suppressing effects without triggering severe nausea or other side effects. The gradual increase helps your body gradually adapt to the drug's mechanisms.
Over a 16-week period, the dose typically escalates through 0.5 mg, 1.0 mg, 1.7 mg, and finally 2.4 mg—each step taken weekly or biweekly depending on your provider's protocol. Most people find their weight loss sweet spot somewhere between 1.7 mg and 2.4 mg per week. Clinical data shows that higher doses correlate with greater weight loss, but individual responses vary based on genetics, metabolism, and baseline health. Your provider may adjust your pace or pause at certain dose levels based on your results and tolerability.
Typical Semaglutide Dose Progression Timeline
Week 1 starts with 0.25 mg, establishing baseline tolerability and allowing your brain's appetite centers to begin responding to the medication. Weeks 2–4 maintain 0.25 mg to reinforce this adaptation phase. Week 5 advances to 0.5 mg, doubling the dose as your system tolerates it. By week 9, most patients move to 1.0 mg, and by week 13, they reach 1.7 mg—the dose shown in many clinical trials to produce meaningful weight loss without excessive side effects.
The final step to 2.4 mg typically occurs around week 16 or later, and some people remain on 1.7 mg if they're achieving their weight loss goals and feel well. This timeline is flexible; your healthcare provider may slow the progression if you experience significant nausea, vomiting, or constipation. Once you stabilize at your maintenance dose, you continue that same weekly injection indefinitely as long as you're seeing progress and tolerating the medication. PlexusDx provides all dose strengths through licensed 503A compounding pharmacies, so you can advance through each tier without worrying about cost changes.
Semaglutide Dose and Weight Loss Results
Clinical trials demonstrate a clear dose–response relationship: patients on 2.4 mg semaglutide lose approximately 15% of body weight over 68 weeks, compared to roughly 6% weight loss in the 1.7 mg group and 3% in the 0.5 mg group. However, 'more is not always better'—individual genetics, gut bacteria composition, and hormone sensitivity influence how effectively each dose works for you personally. Some patients achieve their target weight at 1.7 mg and experience excellent results without escalating further. Others plateau and benefit from reaching the full 2.4 mg dose.
The Precision Peptide Genetic Test offered by PlexusDx analyzes genetic variants in your GLP1R, GIPR, FTO, and MC4R genes—markers that predict your likelihood of responding optimally to semaglutide at different dose levels. Knowing your genetic peptide pathway helps your provider personalize your dosing strategy from the start, potentially reducing the trial-and-error phase. Weight loss plateaus often occur between months 3 and 6, but continuing your semaglutide at a stable dose helps you maintain your achieved loss and prevents rebound weight gain.
PlexusDx Compounded Semaglutide: Flat Pricing Regardless of Dose
PlexusDx offers compounded semaglutide injections starting at $149 per month with no hidden dose-based fees or price escalation as your dose increases. Your dose may need to go up, but your price won't—this pricing transparency removes the financial anxiety many patients feel when progressing through standard titration schedules. All medications are prepared by licensed 503A compounding pharmacies, meaning they meet stringent pharmaceutical standards and are custom-formulated specifically for your treatment needs.
Signing up requires no insurance, no membership fees, and no prior authorization delays. PlexusDx serves all 50 states and accepts HSA and FSA funds, making personalized semaglutide therapy more accessible than ever. After your first month of treatment, you have the option to add the Precision Peptide Genetic Test ($99 one-time) to unlock insights about your genetic response to peptide therapies. This genetic data informs your provider's dosing decisions and increases the likelihood of finding your optimal therapeutic dose faster.
Common Questions About Semaglutide Dosing Safety
Starting at the lowest dose minimizes side effects and allows your body to adapt safely before escalating. The most frequent early side effects—nausea, vomiting, and loose stools—occur at lower frequencies when you begin at 0.25 mg and advance slowly. If you experience severe symptoms, your provider can pause at your current dose for an extra week or two, or even step back to consolidate tolerance. This flexible approach is safer than jumping straight to 2.4 mg, which would overwhelm your system.
Long-term safety data supports semaglutide use at all dose levels when prescribed and monitored by a healthcare provider. Rare but serious risks include pancreatitis and gallbladder complications, which is why ongoing check-ins with your provider are essential. PlexusDx partners with licensed compounding pharmacies to ensure medication purity, potency, and sterility—reducing contamination risks compared to street or overseas sources. Always disclose your full medical history, current medications, and family history of thyroid cancer or multiple endocrine neoplasia before starting semaglutide.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the standard starting dose of semaglutide for weight loss?
The standard starting dose is 0.25 mg injected subcutaneously once per week. This low entry point minimizes nausea and other side effects while allowing your body to adapt to the medication's appetite-suppressing effects. Your provider will gradually increase your dose every 1–2 weeks based on your tolerance and response.
How long does it take to reach the full semaglutide dose?
Reaching the maintenance dose of 2.4 mg typically takes 16 weeks, progressing through 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, and finally 2.4 mg. However, some patients achieve excellent weight loss at 1.7 mg and stop titrating there. Your provider may adjust the timeline based on your side effects and progress.
Does PlexusDx charge more as my semaglutide dose increases?
No. PlexusDx semaglutide injections start at $149 per month with flat pricing across all dose levels. Your dose may need to go up, but your price won't—you never pay more as you advance through the titration schedule.
What if I experience severe nausea at my current semaglutide dose?
Severe nausea is a signal to pause or slow your dose escalation. Your provider can extend your stay at the current dose for an extra week or two, try anti-nausea strategies, or in rare cases step back temporarily. Starting low and going slow minimizes this risk from the beginning.
How can the Precision Peptide Genetic Test help me with semaglutide dosing?
PlexusDx's Precision Peptide Genetic Test ($99 add-on after month one) analyzes variants in GLP1R, GIPR, FTO, and MC4R—genes that predict your individual response to semaglutide. This genetic insight helps your provider personalize your dosing strategy and may reduce the trial-and-error phase, getting you to your optimal dose faster.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Ozempic and Nausea: Why Does Ozempic Make You Throw Up After Eating?
Optimizing Your Ozempic Journey: When is the Best Time to Take an Ozempic Shot?